ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pfizer Initiates for 20-Valent Pneumococcal Conjugate Vaccine Phase 3 Program
December 17, 2018Pfizer announced the initiation of a Phase 3 program for its 20-Valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, for the prevention of invasive disease and ..... -
Alzheon says data back plans for phase 3 program
July 26, 2018Alzheon is still trying to build a case for a pivotal trial of its Alzheimer’s candidate, and the company says it has new data backing up the drug’s use in patients genetically predisposed to develop the disease.
Pharma Sources Insight January 2025
